Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
investigators plan to conduct a multicenter, prospective, randomized controlled, open, phase clinical study to compare the efficacy and safety of nimotuzumab with concurrent chemoradiation alone in elderly participants with advanced esophageal squamous cell carcinoma.
Epistemonikos ID: 75dfa1c4e622ba9069852fa3d782a55e86fc1d48
First added on: Jun 01, 2025